081033726	081033726	CD	B-NP	O
|	|	NN	I-NP	O
CCHO	CCHO	NN	I-NP	O
|	|	NN	I-NP	O
90779059	90779059	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1640338	1640338	CD	B-NP	O
|	|	CC	I-NP	O
10/6/2004	10/6/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2004	10/6/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2005	11/22/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MANCHE	MANCHE	NNP	B-NP	O
,	,	,	O	O
EARLE	EARLE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Stage	Stage	NN	B-NP	O
IV	IV	CD	I-NP	O
esophageal	esophageal	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

PRESENTING	PRESENTING	VBG	B-VP	O
SYMPTOMS	SYMPTOMS	NNP	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Kanaan	Kanaan	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	O
IV	IV	CD	I-NP	O
esophageal	esophageal	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
his	his	PRP$	B-NP	O
third	third	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
note	note	NN	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
three-pillow	three-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
sleeping	sleep	VBG	I-VP	O
both	both	DT	B-NP	O
upright	upright	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
walking	walk	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mall	mall	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
accomplish	accomplish	VB	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
ADLs	ADL	NNS	I-NP	B-protein
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
feet	foot	NNS	I-NP	O
without	without	IN	B-PP	O
becoming	become	VBG	B-VP	O
severely	severely	RB	B-ADJP	O
dyspneic	dyspneic	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
describe	describe	VB	I-VP	O
having	have	VBG	B-VP	O
diminished	diminish	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
copious	copious	JJ	B-NP	O
watery	watery	NN	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-VP	O
treated	treat	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
esophageal	esophageal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
stage	stage	NN	I-NP	O
IV	IV	CD	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
chemo	chemo	NN	I-NP	O
x3	x3	NN	I-NP	O
cycles	cycle	NNS	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
and	and	CC	O	O
AICD	AICD	NN	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
vasculitis	vasculitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
CAD	CAD	NN	B-NP	O
.	.	.	O	O

OUTPATIENT	OUTPATIENT	JJ	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
,	,	,	O	O
Atrovent	Atrovent	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Prilosec	Prilosec	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
95.8	95.8	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
90/60	90/60	CD	B-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
oxygenation	oxygenation	NN	I-NP	O
was	be	VBD	B-VP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
uncomfortable	uncomfortable	JJ	I-ADJP	O
sitting	sit	VBG	B-VP	O
straight	straight	RB	B-ADVP	O
up	up	RB	I-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
visibly	visibly	RB	B-ADJP	O
tachypnic	tachypnic	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
scattered	scatter	VBN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
and	and	CC	O	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
15	15	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
exam	exam	NN	I-NP	O
reveled	revel	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
prominent	prominent	JJ	B-NP	O
S3	S3	NN	I-NP	B-protein
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	B-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
46	46	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2960	2960	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
48	48	CD	I-NP	I-protein
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	B-protein
0.1	0.1	CD	I-NP	I-protein
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
44.5	44.5	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
7.8	7.8	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
D-dimer	D-dimer	NN	B-NP	B-protein
was	be	VBD	B-VP	O
150	150	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
palliative	palliative	JJ	I-NP	O
esophageal	esophageal	JJ	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
4/5/05	4/5/05	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
exam	exam	NN	B-NP	O
and	and	CC	O	O
labs	lab	VBZ	B-VP	O
findings	finding	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
strict	strict	JJ	B-NP	O
I	I	NN	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diureses	diures	NNS	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	I-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
85	85	CD	B-NP	O
to	to	TO	B-PP	O
110	110	CD	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
82.1	82.1	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
87.5	87.5	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
slight	slight	JJ	B-NP	O
leak	leak	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.1	0.1	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
x3	x3	NN	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
trend	trend	VB	I-VP	O
to	to	TO	B-PP	O
higher	high	JJR	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
maximized	maximize	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
or	or	CC	O	O
statin	statin	NN	B-NP	O
and	and	CC	I-NP	O
baby	baby	NN	I-NP	O
aspirin	aspirin	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
him	him	PRP	B-NP	B-cell_type
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
spironolactone	spironolactone	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
in-house	in-house	VBP	B-VP	O
to	to	TO	I-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
liter	liter	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
,	,	,	O	O
nesiritide	nesiritide	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lasix	Lasix	NN	B-NP	B-protein
drips	drip	NNS	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
responsive	responsive	JJ	I-ADJP	O
to	to	TO	B-PP	O
combination	combination	NN	B-NP	O
of	of	IN	B-PP	O
nesiritide	nesiritide	NN	B-NP	O
and	and	CC	I-NP	O
dopamine	dopamine	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulatory	ambulatory	JJ	B-NP	O
saturations	saturation	NNS	I-NP	O
of	of	IN	B-PP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
overnight	overnight	RB	B-ADVP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
symptomatic	symptomatic	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
completed	complete	VBN	I-VP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
earlier	earlier	RBR	B-ADVP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
colchicine	colchicine	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
flare	flare	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
gout	gout	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
to	to	TO	I-VP	O
treat	treat	VB	I-VP	O
this	this	DT	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
palliative	palliative	JJ	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
esophagus	esophagus	NN	I-NP	O
on	on	IN	B-PP	O
4/5/05	4/5/05	CD	B-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
placed	place	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cap	Cap	NNP	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
is	be	VBZ	B-VP	O
outpatient	outpatient	NN	B-NP	O
oncologist	oncologist	NN	I-NP	O
for	for	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
esophageal	esophageal	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.3	1.3	CD	I-NP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
briefly	briefly	RB	B-ADVP	O
required	require	VBD	B-VP	O
having	have	VBG	I-VP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
problems	problem	NNS	B-NP	O
with	with	IN	B-PP	O
voiding	void	VBG	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
exhibit	exhibit	VB	I-VP	O
some	some	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
than	than	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
gout	gout	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
was	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
and	and	CC	I-VP	O
do	do	VB	I-VP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
resting	rest	VBG	I-VP	O
comfortably	comfortably	RB	B-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Crackles	Crackle	NNS	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
notably	notably	RB	I-VP	O
diminished	diminish	VBN	I-VP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
was	be	VBD	B-VP	O
tachypnic	tachypnic	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
S3	S3	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
trace	trace	NN	B-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Trazodone	Trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Multivitamins	Multivitamin	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Keltt	Keltt	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-2412165	0-2412165	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RENEAU	RENEAU	NNP	B-NP	O
,	,	,	O	O
DEVON	DEVON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SASHINGTON	SASHINGTON	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8329447	8329447	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/13/05	10/13/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/13/05	10/13/05	CD	B-NP	O

